Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001796011-20-000002
Filing Date
2020-09-02
Accepted
2020-09-02 10:52:57
Documents
1
Effectiveness Date
2020-09-02
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 13049
  Complete submission text file 0001796011-20-000002.txt   14191
Mailing Address 601 LEXINGTON AVENUE, 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE, 54TH FLOOR NEW YORK NY 10022 2127396400
OrbiMed Asia Partners IV, L.P. (Filer) CIK: 0001796011 (see all company filings)

EIN.: 843786860 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-362067 | Film No.: 201155998